Provided by Tiger Trade Technology Pte. Ltd.

Acurx Pharmaceuticals, LLC*

1.26
-0.0450-3.45%
Post-market: 1.280.0200+1.59%19:55 EDT
Volume:130.50K
Turnover:165.28K
Market Cap:6.89M
PE:-0.41
High:1.32
Open:1.32
Low:1.23
Close:1.31
52wk High:8.34
52wk Low:1.23
Shares:5.47M
Float Shares:5.34M
Volume Ratio:1.43
T/O Rate:2.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0454
EPS(LYR):-5.3153
ROE:-128.11%
ROA:-55.92%
PB:0.85
PE(LYR):-0.24

Loading ...

Acurx Pharmaceuticals Price Target Maintained with a $31.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 29

Acurx Pharmaceuticals Announces First Patient Enrolled in Pathfinder Clinical Trial of Ibezapolstat in Multiply-Recurrent C. Difficile Infection

THOMSON REUTERS
·
Sep 29

Acurx Pharmaceuticals - Files for Resale of 1,500,000 Common Shares - SEC Filing

THOMSON REUTERS
·
Sep 09

Acurx Pharma Announces Annual Shareholder Meeting

Reuters
·
Sep 02

Analysts Offer Insights on Healthcare Companies: Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP)

TIPRANKS
·
Aug 20

Acurx Pharmaceuticals Receives FDA Conditional Acceptance and Uspto Trademark Allowance for the Company's Brand Name for Ibezapolstat

THOMSON REUTERS
·
Aug 17

Analysts Are Bullish on Top Healthcare Stocks: Candel Therapeutics (CADL), Acurx Pharmaceuticals (ACXP)

TIPRANKS
·
Aug 14

Acurx Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Acurx Pharmaceuticals Q2 EPS $(0.53) Misses $(0.37) Estimate

Benzinga Earnings
·
Aug 14

Acurx Pharmaceuticals Q2 EPS USD -0.53

THOMSON REUTERS
·
Aug 14

Press Release: Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 Results and Provides Business Update

Dow Jones
·
Aug 14

Acurx Net Loss Flat at $2.26 Million in Q2 2026

Reuters
·
Aug 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 13

ACXP Advances Ibezapolstat Trial in High-Risk C. Difficile Patients

TIPRANKS
·
Aug 13

Acurx Pharmaceuticals Inc Expected to Post a Loss of 38 Cents a Share - Earnings Preview

Reuters
·
Aug 12

Acurx Says Japan, Mexico Patent Offices Grant New Patents for DNA Polymerase IIIC Inhibitor Antibiotics

Reuters
·
Aug 12

Acurx partners with Leiden University Medical Center to develop its antibiotics

TIPRANKS
·
Aug 10

Acurx Partners with Leiden UMC to Develop First 3D Structure of MRSA PolC Bound to Its Antibiotic Inhibitor

Reuters
·
Aug 10

Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx's DNA Polymerase Iiic Inhibitor Antibiotics

THOMSON REUTERS
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Acurx Pharmaceuticals (ACXP)

TIPRANKS
·
Aug 03